Bodal Chemicals Limited (524370) Earnings Call Transcript & Summary
August 16, 2021
Earnings Call Speaker Segments
Operator
operatorLadies and gentlemen, good day, and welcome to the Q1 FY '22 Earnings Conference Call of Bodal Chemicals Limited. This conference call may contain forward-looking statements about the company which are based on the beliefs, opinions and expectations of the company as on date of this call. These statements are not the guarantees of future performance and involve risks and uncertainties that are difficult to predict. [Operator Instructions] Please note that this conference is being recorded. I now hand the conference over to Mr. Ankit Patel, Executive Director of Bodal Chemicals Limited. Thank you, and over to you, sir.
Ankit Patel
executiveThank you very much. Good afternoon, everybody. On behalf of Bodal Chemicals Limited, I extend a very warm welcome to everyone for joining us on our call today. On this call, we have our CFO, Mr. Mayur Padhya; and SGA, our Investor Relations advisers. I hope everyone has got an opportunity to go through the financial results and investor presentation, which has been uploaded on the stock exchanges as well as our company's website. We will give you a quick overview on recent development of our company, and then Mr. Padhya will talk you through the financial performances for the quarter. We are a 3-decade-old organization and has been recognized as integrated dyestuff chemical manufacturer in global market. We are one of the largest manufacturers and exporters of chemical products in dyestuff, dye intermediates and basic chemicals and its variants. Over the last few years, we are moving up the value chain and working towards diversifying the business from our core Dyestuff, Dye Intermediates business to other specialty chemical products like benzene derivatives and chlor alkali products. We are moving forward with a very focused mindset and adding additional capacity across multiple products. The performance for the quarter -- overall performance for the quarter has been marginally impacted as we were working with a limited workforce in the month of May due to a sudden spike in COVID cases. For Q1 FY '22, total income on consolidated basis stood at INR 428 crores, whereas on the stand-alone basis, total income stood at INR 394 crores. We will parse the -- each business vertical and their recent developments. Dyestuff. We are producing around 175 variants of dyestuff, which are principally used as raw materials in textiles, leather, paper and other dyestuff-consuming industries. Textile industry constitutes around 80% of the total dyestuff demand. Dyestuff business has been moderate in the last financial year as demand has been soft due to pandemic, although we are actually seeing a sign of demand recovery over the last couple of months. For Q1 FY '22, Dyestuff segment contributes around 31% of our total revenue. In terms of production, we are among the top 3 manufacturers in India and are in good position to recover as demand revives. We are happy to announce that our liquid dyestuff has also contributed well during the quarter. Dye Intermediates. We produce around 25 dye intermediate products and are the leading player in domestic market. More than 40% of dye intermediates capacity is captively consumed for various dyestuff, which gives us a cost competitive advantage. In Q1 FY '22, the average price of vinyl sulphone was around INR 259 per kg, and H-acid was around INR 404 per kg, respectively. For the quarter, Dye Intermediates segment contributed around 36% of our total revenue. Basic Chemicals. We manufacture many basic chemicals like sulfuric acid, chlorosulphonic acid, oleum, beta naphthol, acetanilide, et cetera. These chemicals are used as key raw materials for production of dye intermediates, which is highly beneficial in terms of improved profitability of the company. 48% of our basic chemical capacity are captively consumed continued for dye intermediates production. Thionyl chloride has witnessed good production performance during the quarter, and expect the momentum to continue in FY '22. Our overall Basic Chemicals segment contributes around 13% of total revenue. Chlor Alkali business. during the quarter, we have successfully acquired our Rajpura, Punjab unit from Mawana Sugars. This unit produces chlor alkali products, including caustic soda, stable bleaching powder, hydrochloric acid, et cetera, which has contributed well with a revenue of INR 49 crores for Q1 FY '22. The key product, caustic soda, has a capacity of 82,500 tonnes per annum, which -- with 70% of -- would be operational for the FY '22. This unit is currently going under technology upgradation to improve the capacity to 99,000 tonnes per annum and significant reduction in the power cost. This unit already has very strong client base and has been supplying to leading companies like HUL, Nestlé, IOC, HPCL, Vardhman, Trident, et cetera. We expect this unit to generate additional revenues of around INR 300 crores at optimum levels with EBITDA margins in the range of 20% to 22%. Benzene derivatives and sulfuric acid at Saykha. Our Saykha greenfield project is in progress, and we are planning to bring it on stream by Q3 FY '23. Under Benzene downstream products, we will be manufacturing MCB, PNCB, ONCB, MNCB, DNCB, PNA, 2,4-DNCB and MPDSA, which are used in chemicals, pharma and agrochemicals. The capacity of sulfuric acid and derivatives will 340,000 tonnes per annum, which would include sulfuric acid, Oleum 23%, Oleum 65%, liquid SO3, chlorosulphonic acid and SO2. We will set up 4-step integrated product chain, which should lead to the cost efficiency, better productivity and higher margins for the company. We expect this project to generate additional revenues of around INR 550 crores at optimum utilized levels and EBITDA margins of 15% to 18%. In other developments of Bodal, production of TCCA has been stabilized and has contributed around INR 18 crores, which is 4% of total revenue. We expect this momentum to continue. We have multiple trading and marketing subsidiaries to penetrate new geographies and clients. Comparatively, all key subsidiaries have performed well. Our Turkey subsidiary, Sener Boya's sales has improved meaningfully. However, the foreign exchange loss has impacted the profitability due to the depreciation of lira against U.S. dollar. On business front, we expect monthly dispatches to improve further going ahead at Sener Boya, Turkey. Bodal China has performed well and has turned profitable. We expect all our subsidiaries to perform well and turn profitable in coming quarters. In a medium- to long-term view, these subsidiaries will penetrate their respective regions and bring meaningful business to our company. We have implanted the roots of new chemistry, new clients, new geography diversification, investing in integration to create long-term, sustainable growth. New chemistries will add annual revenues of around INR 800 crores with better margin as compared to our existing business. Additionally, these businesses are more stable and will bring sustainable growth to our company. Thank you. And now I hand over the call to Mr. Mayur Padhya to walk you through the financial performance.
Mayur Padhya
executiveGood afternoon, everyone. Our business was marginally impacted as we were working with limited workforce in the month of May due to a sudden spike in COVID cases, although we were able to register a healthy business for the quarter. Now the stand-alone performance for Q1 FY '22 are as follows. Total revenue for Q1 FY '22 stood at INR 3,940 million. Performance on year-on-year is not comparable due to nationwide lockdown in Q1 FY '21. EBITDA stood at INR 539 million in Q1 FY '22. Net profit for the quarter stood at INR 301 million. Our consolidated performance for the quarter is as below. Total revenue stood at INR 4,282 million. Out of total revenue, 35.6% were contributed by export, whereas balance, 64.4%, were contributed by domestic sales. EBITDA stood at INR 553 million in Q1 FY '22. Net profit for the quarter stood at INR 288 million. Turkish lira had been volatile especially during the month of April. [Technical Difficulty]
Operator
operatorLadies and gentlemen, we lost the line of the management. We would request you to please continue to hold while we join them back. Thank you.
Mayur Padhya
executiveYes. So I was discussing consolidated performance for the quarter. And I was mentioning EBITDA stood at INR 553 million in Q1 FY '22. Net profit for the quarter was INR 288 million. Turkish lira has been volatile, especially during the month of April, and it has impacted the Sener Boya's result. And there was a mark-to-market exchange loss of about INR 20 million. This has impacted our consolidated financial. On the subsidiary front, SPS posted revenue of INR 310 million. Our Bodal Chemicals Trading Private Limited subsidiary has reported a revenue of INR 21 million. Sener Boya's performance was notable during the quarter, which has reported total income of INR 331 million. Total income from Chinese subsidiary was INR 154 million. Segment-wise revenue on consolidated basis: Dyestuff stood at about INR 1,311 million. Dye Intermediates revenue stood at INR 1,522 million. Basic Chemicals revenue stood at INR 533 million. So Chlor Alkali Division's revenue stood at INR 497 million. TCCA revenue stood at INR 181 million. Total production volume on stand-alone basis for Q1: Dyestuff reported 3,836 metric tonnes, Intermediates reported 6,070 metric tonnes, Basic Chemicals stood at 57,412 metric tonnes, Chlor Alkali stood at 18,928 metric tonnes and TCCA stood at 710 metric tonnes for the quarter. With this, I'll conclude the presentation and open the floor for further discussion, particularly question and answer.
Operator
operator[Operator Instructions] The first question is from the line of [ Moresh Johan ] from IDBI Capital.
Unknown Analyst
analystSir, I have 2 questions. First is on margins. What kind of margins do we see that are sustainable in our current business? EBITDA margin, I'm talking?
Mayur Padhya
executiveYes. In our current business, we consider about 13% to 15% margin as something very much sustainable considering all the initiatives company has taken for its growth and its integration.
Unknown Analyst
analystOkay. And sir, with regards to our expansion plans, I believe, sir, we are moving towards becoming more of a specialty player. So I would like to know that in 3 years' time, how much portion would be specialty and how much would remain commodity? I mean some ballpark in terms of sales, 80-20, 50-50, whatever.
Mayur Padhya
executiveSo in [ current plan ], so the current growth plan should be executed in the next 6 to 7 quarters. And post that, we are targeting around INR 800 crores to INR 900 crores of turnover from both the main growing areas. And of course, in about 2 to 3 years' time, we are targeting around 25% to 35% of specialty business in the totality.
Unknown Analyst
analystOkay. And what kind of margins that we'll have, that specialty part, 25% to 30%?
Mayur Padhya
executiveWe are targeting around 18% to 20% in the specialty business. And overall, so Chlor Alkali, we are -- we should see around 20%, 25%, and then specialty should be around 20%, and the existing is around 13% to 15%. Overall, we are targeting around 17%, 18% EBITDA.
Unknown Analyst
analystOkay. And sir, those products would be newer for us. Are we hiring new people for that? And what about on the client side? Are we looking for new clients? Or will it take time for us to find clients for that sort of same thing?
Mayur Padhya
executiveWe are definitely hiring the best available talent in India for our many projects. And also, it's something -- definitely something that is an existing business for us. So we already have some of the best talent of the country. But the building part is something new, so we are definitely hiring whatever is available in the market. But we already have good consultants and good people on board for the same. Also for Chlor Alkali, I have ex-GHCL people who are guiding us and the other team members who have a lack of experience in the chlor alkali space. Also, for the overall strategy of the company, we definitely are going into a stronger project team because the growth will continue. And with the -- also, for the commercial part, we are planning to start the commercial activities of our upcoming new products within a couple of quarters. So when the commercialization of the project happens, we will have ready customers and ready experience of [ auxillary ] sales. Also, our Basic Chemicals, we have been active -- we have been an active basic chemicals player since more than 10 years now. And we do -- we already cater to agrochemicals and pharma and other chemical sectors more than 10 years. So we do have, I would say, at least 60%, 70% customers who will come from our existing list. But the remaining 20%, 30%, 40% customers, we'll develop over a period of time.
Operator
operatorAny other questions sir?
Unknown Analyst
analystOh, no, no.
Operator
operator[Operator Instructions] The next question is from the line of Aditya Khetan from Stewart & Mackertich.
Aditya Khetan
analystHello? Am I audible?
Operator
operatorYes, you're audible now.
Aditya Khetan
analystHello? Okay. Sir, just a couple of questions from my side. Sir, first, if you can provide the volume number breakup of exports and domestic for this quarter and for financial year FY '21.
Mayur Padhya
executive[ Foreign Language ]. As far as the sales data, we are not disclosing it. Whatever data we disclose is a production number. So as we have discussed earlier, out of total revenue, 36% is from export and balance is from local. This much that we can share with you. Volume data for domestic as well as local, we are not sharing.
Aditya Khetan
analystOkay. Sure, sure. Sir, on the export side, so our major revenues are towards the Asia and Europe. That is almost 80% of the exports sale. So are you looking to further increase presence towards the other emerging and the advanced economies globally? Or what is the strategy we are working for exports?
Mayur Padhya
executiveSo we already have a presence in South America and North America. While in CCA, mainly we export it to North America and [Technical Difficulty]
Operator
operatorLadies and gentlemen, we lost the line for the management. We request you to please continue to hold while we join them back to the conference.
Ankit Patel
executiveYes. We apologize about this disturbance. I don't know what is happening. We are now on a different line. So hopefully, this will not have a disturbance again. So to answer Aditya Khetan's question about export, the textile and other applications mainly are present there in Europe and Asian countries only. But we do have a market in South America which we cater to as far as export dyestuff is concerned since many years. Also in North America, we -- our majority of supplies of [ PCC ] are done to North America because we have the EPA license to supply in the U.S. So we are definitely opening more territory. We also supply some of our liquid dyes to African continent and also to Australia. So overall, we are present almost everywhere globally. And the idea to open our marketing subsidiaries in China, Indonesia, Bangladesh, et cetera, is that only to have direct business in such areas. And Turkey, Sener Boya has also been doing very well. We've been -- we had increased volumes over last few quarters. So I think things are looking good as far as our marketing subsidiaries go and our exports goes.
Aditya Khetan
analystOkay. Sir, in FY '21, so roughly around 33% of sales was from exports, and this is down from 44% in FY '19. So how you see this in the next 3 to 5 years to move again? So going back in the range of 40% to 45%? Or the focus would be more on the domestic only?
Ankit Patel
executiveWell, our export will go down because our Chlor Alkali business, which we have recently acquired, that is completely a domestic business in North India so that will not contribute. Plus our Saykha greenfield projects where sulfuric acid and derivatives is again a domestic business. In benzene specialty derivatives, there is some export potential. But the new INR 800 crores to INR 900 crores of revenue, I don't think we will be doing more than 15%, 20% of exports from that. So once that is added in 2 years of time, our overall exports will probably come down to 20% to 25%. But at the same time, we will also be growing brownfield projects, most likely in the dyestuff sector. So we'll have some export from there. But overall, if I talk about next 3 to 5 years, we'll -- our exports will go down.
Mayur Padhya
executiveBut if you consider an absolute number, it will increase because our dyestuff production is at present about 55% level. So once we reach to about 75% level, then in absolute number, it will increase. But in proportion to total number, yes, percentage-wise, there will be a decline.
Aditya Khetan
analystOkay, sir. Got it. Got it. Sir, next question is on the other expenses. Other expenses in this quarter has gone up materially. On sequential basis, it is up by almost 50%. How much is the one-off? And what is a sustainable number which we can work in?
Mayur Padhya
executiveNo. In current quarter, there is no -- any exceptional number is there. So there's not we can consider is something sustainable.
Aditya Khetan
analystBut sir, in this quarter, our other expenses as a percentage of sales is almost 29% to 30% as compared to our normal range of 22% to 24%. So definitely, there is a jump in the other expenses. So I just want to understand, is this a sustainable number which we could work going ahead? Or what is the factor that has led to such a sharp jump in this quarter?
Mayur Padhya
executiveWe can do one thing. I do not have an exact number. So you can connect me off-line. We can discuss it in detail later on.
Aditya Khetan
analystSure, sir. Sure, sir. Sir, just one more question. Sir, in this quarter, our chlor alkali capacity, that has operated at 92% utilization levels. Is this number correct, sir? 92% utilization for Chlor Alkali business?
Mayur Padhya
executiveNo. Chlor alkali, our present capacity is 82,500 metric tonnes. And there are a couple of other products for which we do have a capacity like stable bleaching powder as well as sodium hypo and HCL. But if we consider it as a Chlor Alkali business, then our capacity utilization was around 70%, and it will remain around this level until we conclude this modernization of the project. So coming about 6 quarter or 5 quarter, it will remain around 70% only.
Aditya Khetan
analystOkay. Sir, the capacity of chlor alkali, 82,500, correct, sir?
Mayur Padhya
executiveYes, 82,500 metric tonnes per annum.
Aditya Khetan
analystOkay. Sir, just a number which I would like to share is 82,500 metric tonnes. If you divide it by the 4 for this quarter, and the volume numbers you have given, it is 18,928 tonnes per -- tonnes, so if you divide that, we get a number of 92% rate, sir. Like 70% number, how have you arrived at it? If you can share that.
Ankit Patel
executiveNo. So that capacity is usually considered from the caustic production, and the number that we have given includes some of the other products also being produced in the complex. So that 82,500 is our caustic soda production capacity.
Mayur Padhya
executiveAnd stable bleaching.
Ankit Patel
executiveAnd there is another product called stable bleaching powder which you produce there. That is not considered in the capacity of 82,500, but it is considered there in the production volumes.
Aditya Khetan
analystSir. Good, sir. Okay. So what would be the [ auxillary ] capacity, sir?
Ankit Patel
executiveProduction we had is approximately around 14,000 to 15,000 tonnes.
Aditya Khetan
analyst14,000 to 15,000 tonnes. Okay.
Ankit Patel
executiveThis quarter, yes.
Aditya Khetan
analystAnd sir -- and the revenue contribution from chlor alkali in this quarter was INR 49 crores. So how much would be the contribution to EBITDA impact?
Ankit Patel
executiveSo EBITDA, we were negligible EBITDA positive for this quarter.
Aditya Khetan
analystOkay. Okay.
Ankit Patel
executiveModels, did you ask?
Aditya Khetan
analystOkay. And this is because of the older technology so that we would be upgrading all that? Like -- so the company is not...
Ankit Patel
executiveYes. This is absolutely because of the older technology. There are 2 issues. One is that we are not able to run the plant at 90% because it requires a lot of investment into the older technology. So we have decided to run it at around 70% until we upgrade the latest technology. And when the latest technology comes in, we are looking at least INR 30 crores, INR 40 crores overall positivity added in the EBITDA numbers. We are -- this is a conservative number. It could be much higher than that also.
Operator
operator[Operator Instructions] The next question is from the line of [ Arush Agarwal ] from [ Victadelta Securities ].
Unknown Analyst
analystI have a couple of questions. Sir, I wanted to know, what is the current scenario of dyestuff prices in India?
Ankit Patel
executiveSo the current scenario overall is quite stable. Since the second wave slowed down or concluded, things have been getting back on track. So I would say overall situation in the dyestuff demand and the production levels are quite normal at the moment.
Unknown Analyst
analystAnd the second part, how is the current market of vinyl sulphone and H-acid? And what kind of current prices trend are there currently? Do you see any demand-supply gap from this?
Ankit Patel
executiveSo as I said, vinyl sulphone are the main key raw materials to produce the dyestuff. And as I said, the dyestuff demand is quite normal. So acetanilide is directly linked to the dyestuff demand in the market. So I would say that the demand for the HA and VS is also quite normal. I do not see much of a gap currently between demand and supply of H-acid and vinyl sulphone. And the current price of H-acid is around INR 370 to INR 375 per kg, and vinyl sulphone is INR 225 to INR 230 per kg.
Unknown Analyst
analystOkay. And how is the textile market shaping up for us? And are we receiving any inquiries pre-COVID level for our dyestuff and dye Intermediate products?
Ankit Patel
executiveIn dyestuff particularly, we are, I would say, at around 75%, 80% back to the pre-COVID levels. We have reached about 65% of utilization in the Dyestuff business earlier. But now in this recent quarter, we were at around 55%. So there's definitely room. And the dyestuff industry overall is showing good signs only. I think the good volumes are definitely back because of overall disturbance across the globe has minimized. So I think in coming time, I think COVID also at the moment doesn't look like a big threat anymore, at least production-wise or economy-wise. So I think in coming quarters, things should be back to pretty much normal.
Unknown Analyst
analystOkay, sir, that was helpful. And that is from our side.
Operator
operatorThe next question is from the line of [ Santina Rathi ] from S.K. Securities.
Unknown Analyst
analystSo I had a couple of questions. So could you just throw some light on the benzene derivatives with respect to the client profile?
Ankit Patel
executiveCan you repeat the question, please?
Unknown Analyst
analystYes. Sir, could you just throw some light on the benzene derivative segment on the basis of client profile?
Ankit Patel
executiveYes. So for client profile, okay. What we are doing in benzene derivatives is we are going in with a 4-step integration from Phase 1 only. We are not going to produce 1 or 2 key products, we are going to produce 6 products and which will be 4-step integration. Also, we are setting up a sulfuric acid complex in that same complex where the waste heat, which is going to generate power and steam, will be completely utilized by all the benzene products. So this integration is very important, which will have a value of more than INR 20 crores, INR 30 crores per annum. Plus, there are -- there's a hazardous byproduct, which is generated in benzene -- one of the benzene plants, which will be completely used by ourselves or the sulfuric acid derivatives. Also, there is some integration between sulfuric acid products and benzene products that we are doing. So there are multiple synergies and integration between both the projects and within the benzene derivatives also. So in benzene, as I said, we are doing 4 step. We are going to produce MCB, from which we are going to produce PNCB and ONCB. PNCB has a main application into dyestuff, dye intermediates mainly into pharmaceutical. Main area is paracetamol. And ONCB has a good application again into dyestuff and agrochemicals. So that's -- those are the 2 products which we'll be using captively because we use PNCB captively and we are going to produce something. We are going to produce OA, which is produced from ONCB. which, again, we use captively in our Dyestuff, Dye Intermediates business. From PNCB, we are going to produce PNA and 2,4-DNCB. So currently, we consume a lot of PNA. So again, that will be linked to our Dye Intermediates business. From PNCB, we are going to produce 2,4-DNCB which is, again, one of the key raw materials which are 2 limited users and a couple of other large companies use. So that will go into a specialized Dyestuff segment called sulfur black. Also, we are going to produce MPDSA from 2,4-DNCB. So MPDSA is one of the key raw materials which we don't produce at the moment. It is a dye intermediate. So we are basically integrating sulfuric acid complex and benzene and derivatives within the complex. Also, we are integrating all the products produced in the benzene derivatives to our Dyestuff and Dye Intermediates business model. So there are a lot of synergies that are going to happen internally in Saykha and also with our existing Dyestuff business.
Unknown Analyst
analystOkay. Okay. That was quite extensive, sir. So could you just highlight if we are in touch with a few clients for all these products and segmentations? And so how big is the market size in India? And how much of it is done through importers, sir?
Ankit Patel
executiveSo 2,4-DNCB, there are 2 large players in both our existing buyers, Atul Ltd and there is another company. For PNCB, obviously, we are going to use it captively. Plus, around 50%, 60%, we are going to sell in the market, which is a net import product. So for PNCB, the paracetamol players are -- some of them are already our buyers, and we already know a majority of the buyers, the large buyers. So selling that is not going to be an issue. ONCB is now going through some of the agrochemicals which are already our clients from our Basic Chemicals segment. MCB, we are not going to sell anything in the market. MCB, we are going to captively use the entire production. MCB also is in dye intermediates. So us being the largest dye intermediate player, it should be -- it's all our same client based off dyestuff players across India for us. So it is going to be part of our same sales strategy for dye intermediates. And PNA, again, we'll be using captively. And PNA, again, goes into to dyestuff manufacturing, dye intermediates manufacturing. So we'll have those similar -- same buyers which we've been catering since many years. And sulfuric acid, we already have 500 tonnes per day plant in Baroda since more than 10 years. So it'll just be an extension of those same -- similar buyers and similar products.
Unknown Analyst
analystAll right, sir. Sir, like one more question I had, so when it comes to TCCA segment and thionyl chloride business, so how are these verticals performing? And like are these verticals profitable? Or could you just throw some color on it and the application and expected revenue on the annual basis?
Ankit Patel
executiveSo TCCA is -- has a main application into cleaning pools, swimming pools. And India does have a sizable market, but we sell it to the premium market, which is the U.S., and we've had a special permission -- certificate to sell the TCCA in the U.S., so -- which is, again, a premium market. In India, Indian market is normally catered by a lower-quality product, which is usually imported from China and et cetera countries. So TCCA has turned profitable for us since the previous quarter. And we are looking at increasing -- debottlenecking some of the things in the plant and maybe increase the capacity by 20%, 30% in coming 1 or 2 quarters. And for TC, thionyl chloride, that has main application into dye intermediates and agrochemicals. So it is a very -- one of the key raw materials for vinyl sulphone and also for the agrochemicals. So all the large players of agrochemicals are our buyers. And so TC also has been running profitable since -- almost since inception.
Unknown Analyst
analystOkay. Sure. Sir, actually, we have already discussed something on the Chlor Alkali business' capacity utilization. So do you mind just like explaining a bit about the product apart from caustic soda and maybe the end users for an application for the [ falling ] products?
Ankit Patel
executiveSo there are -- other than caustic soda, there is chlorine that is going -- that is being produced at our chlor alkali plant in Punjab. We have 5 joining pipeline buyers which is very important for chlor alkali plant. And so about 50% of our chlorine is sold via pipelines to those buyers, and the other remaining 50% is sold via tunnels, cylinders to the North Indian territory, which, again, has an application into food processing and textiles and paper mills, et cetera. And there are many sizable large players in North India. So we don't have to sell even into Rajasthan. We are comfortably selling all our volumes from UP to Haryana to Himachal and Punjab and Jammu and Kashmir. So that -- those areas have a good market, and the market is also growing. There is another product called stable bleaching powder. So we are currently in the process of expanding that plant also. Since it is a brownfield expansion, it is going to cost us very less. And we are trying to become India's third largest player in that segment where Grasim Industries is the largest player. And we are going to -- we are planning to increase our capacity by around 60%, 70%. So that should also be operational in about 6 months' time. And other than this, hydrogen is being produced there. And again, we have a buyer which is adjoining the complex and which buys via pipeline. So that, again, is a strong point for that complex. And other than that, there are a couple of small products like sodium hypo and sulfuric acid. So those are very small in terms of volume and price.
Unknown Analyst
analystAll right. Sir, that was quite extensive. That's all from my side.
Operator
operator[Operator Instructions] The next question is from the line of Saket Kapoor from Kapoor & Co.
Saket Kapoor
analystSir, first point is regarding the employee cost, sir. Anything one-off, sir, for this quarter? Or why have we seen this? How will you explain this increase, sir, for this quarter?
Mayur Padhya
executiveSee, the increase in this quarter is mainly because of induction of Chlor Alkali business in this. So Punjab complex was there -- was not there earlier. And in this quarter only, this has got inducted in the company's business. So increase is mainly because of the addition of these unit.
Saket Kapoor
analystSo now we can look for this as an annualized figure, this quarter number for employee cost?
Mayur Padhya
executiveCorrect, this figure as well as some increment would be there. So -- and some project employee induction will be there. So there can be some improvement from this figure, some increase in this figure.
Saket Kapoor
analystOkay. Sir, regarding the modernization of the caustic unit, sir, this technology are -- is there currently and where -- which one are we migrating to? And what is the amount that will we spend and the commercialization period?
Ankit Patel
executiveSo the existing technology is owned by INEOS, which is a British company, the largest chemical -- one of the largest chemical companies in the world. But being an older technology, it consumes a lot of power. So we have no choice but to upgrade so we can be competitive where it can bring savings of more than INR 30 crores, INR 40 crores annually. There are 2 technologies which are active in India. One is German, which is owned by thyssenkrupp, which is a Fortune 500 company. And the second is AKCC, Asahi Kasei Corporation (sic) [ Asahi Kasei Chemicals Corporation], that is based in Japan, which is, again, a multibillion dollar organization. So we have opted for AKCC, which is Japanese, which is installed at the companies like DCMs, Aditya, Meghmani and some of the Grasim and some of the other plants. So we have opted with Japanese. We confirm them. We've already paid them and it's in the process. We are targeting to complete the modernization by next September or October. And at the same time, so the cost of the -- just the technology part is around INR 45 crores to INR 50 crores. But at the same time, we are increasing the capacity of the plant also, and we are also upgrading a lot of the things in the plant which can help us utilize the capacity more. So overall, we are spending around INR 120 crores, which will -- the spending and the execution should be done by next October, which will bring in -- around revenues of around INR 300 crores. And we are targeting around 20%, 22% EBITDA.
Saket Kapoor
analystBut -- and the capacity will be enhanced to what level, sir? What is the current capacity? And what are we envisaging where...
Ankit Patel
executiveCurrent capacity was 82,500 tonnes per annum. We are increasing it up to 99,000 tonnes per annum. And we are also increasing the capacity in our other plants for stable bleaching powder, where also we are increasing the capacity.
Saket Kapoor
analystOkay, sir. And this is the membrane cell technology that is relevant now?
Ankit Patel
executiveYes, yes. So I think all the technologies across the board now is in membrane cell because the other were not environment friendly, and they have all been out of the market.
Saket Kapoor
analystSir, it seems that power is a very dominant cost in the caustic soda industry. So what steps are we taking to lower the cost of production in the form of power and fuel cost? Were there any investment in the renewable segment we are planning?
Ankit Patel
executiveSo we have explored the possibilities of solar power, because we do have a luxury of a lot of land in the Punjab complex. We are studying that market, what the cost is and what -- how the state government and the electricity board are offering. But since we are committed to this modernization and expansion project for now, we are not planning to do any further CapEx for Punjab. In states like Gujarat and Maharashtra, the power cost from the electricity board is more than INR 7 per unit. So that's why the plants here usually go for captive power plants. But in north, captive power plant concept is not very popular or not the best economically viable because the Punjab state is already offering us around INR 6.3 per unit. So we -- they are already offering us a subsidized rate. And also, to set up a thermal power plant, the majority of the good quality coal have to be supplied from Gujarat ports, which is imported coal. So it will definitely have a higher power production cost than Gujarat plants. So it's not the most economically viable. But we are still exploring some of the other options. There are some bio-based power plants in Punjab which are very common there. So we are exploring those options. But we are not planning to do anything about power plant or anything until we are done with the upgradation. So it can come into second phase next year.
Saket Kapoor
analystAnd lastly, sir, in the caustic soda price trend, though, have you seen substantial improvement over what the March quarter was? And we exited the June quarter at higher ECU?
Ankit Patel
executiveSo caustic soda prices definitely increased a lot. March quarter price was probably around INR 22,000, INR 23,000 per tonne. In June quarter, definitely higher by INR 3, INR 4. Currently, the prices have even further gone up by INR 3, INR 4 more. So around INR 30 per kg is there. But again -- so chlorine and caustic have this combination. And chlorine prices, which are -- at a time were around INR 8, INR 7 per kg, has come down to now INR 2, INR 3 per kg. So -- but still the ECU realization compared to March quarter is definitely better. Compared to June quarter, the existing ECU is also slightly better. There are a couple of plants in the U.S., one plant has shut down, Olin Corporation, which is the largest chlor alkali player in North America. They are -- they have a plan to stop some of their old plants. So 1 product, 1 plant has already stopped. They -- I think they are planning to stop a couple of more plants in coming time. So I think that has affected the overall caustic international demand. And there is always -- so that is actually -- is good for Indian, especially Gujarat, players at the moment. And Gujarat players are exporting caustic already since last about a month in large quantities.
Saket Kapoor
analystOkay, sir. And what is the capacity that has come under shutdown, sir? And the total market which is catered at the U.S. unit, sir?
Ankit Patel
executiveI'm not sure about the exact number, but I think it was a very old plant, so it could be in the range of around 50,000 to 80,000 tonnes per annum. So it was a small plant. But they are planning a couple of more shutdowns. So like 3 years back when there were a 15-, 16-plant shutdown in Europe and in Houston, there were some issues. So I think there are also some plans shut down for a few months. So because of that, the caustic prices went from INR 25, INR 27 levels to INR 50 levels. So it does -- those American and European plants definitely have an effect if they shut down temporarily or long term.
Saket Kapoor
analystOkay. And my last question is, sir, what is the import number, sir, for caustic soda for the last -- from the first quarter of this fiscal year for the country? Any understanding, sir, if it's on a competitive basis? But March versus June, what was the import?
Ankit Patel
executiveNo, it is usually negligible. So Gujarat, there are hardly any imports, only some -- usually, there's some Middle East material that comes in, but it is not a regular trend because Gujarat itself having all these production capacities now. And Gujarat definitely has a lot of pressure because few new expansions have come up, and there are a couple of still large plants due to start this year. So I think scenario in Gujarat is going to be a little pressurized. And there are some imports that take place in Maharashtra regularly because there are hardly any plants in Maharashtra. But Gujarat, there are no regular imports. So us being a buyer in Gujarat, we buy large quantities of caustic, but we hardly buy. So there is hardly any material available here in Gujarat.
Saket Kapoor
analystBut sir, integrally, how does this caustic soda -- based in our supply -- and I was talking about country as a whole, since, sir, I think for the requirement of the country, there is still substantial import of caustic soda that happens annually. I was looking for the entire country number. If you could give -- and how does this caustic soda part play in our story, sir? Or is it a complete diversification to our set of chemicals?
Ankit Patel
executiveSo it does have a slight integration. Our H-acid plant in the subsidiaries, SPS Processors, so that uses caustic soda. Also, we are about to start our vinyl sulphone plan there in 1 or 2 months' time. So that also, again, uses a lot of caustic soda. So it is around 300 kilometers from our Punjab plant to that intermediate plant in UP. So that is the one integration that's going to take place. It definitely was a diversification plan for us because the unit was available at a very attractive price. It needed a lot of effort to turn around and a large investment also. So we were prepared for everything. We are already seeing the turnaround effort other than the investment to upgrade the technology. So we are very confident that other than the technology, we will be able to turn around the overall low production of the plant and some of the old machineries and technology. And so we should be able to -- we are also making a lot of changes in the commercial front in purchase and sales also. So it was -- plus it comes in with 60, 70 acres of spare land. We can definitely integrate this unit further. It's already integrated into 2, 3 products. We want to -- we may -- we can -- we have an option to increase the capacity, which is always a good idea for chlor alkali to bring down the overhead cost. Or we can definitely -- there are a lot of products which are integrated within the chlor alkali space, are supplied from Gujarat to North India on a regular basis. So we can also consider to set up those projects in North India. So we do have a lot of options. But currently, as I said, we are committed to this upgradation and expansion. So once we are done and whenever it is the best time financially for us, we do have the land and all the required permissions from the environment front also are available there. So in the long term, what I can say is we can have one area -- one growth area which can come from Punjab, which has a lot of spare land and a good chemical manufacturing environment over there, and also a steady increase in the demand. So it could be maybe INR 600 crores to INR 800 crores of turnover block for us that can come from Punjab. And again, we are already working on Saykha, which can bring -- which is going to bring in INR 500 crores of revenue. Again, we are not utilizing the total land there. So we can -- we are planning to further integrate and bring in more products in Saykha also. So we also have a 10-year plan there. So again, that can become, again, INR 1,000 crore-plus block for us. And our existing business also has some brownfield possibilities. So overall, we are putting together 3 different sites. One is greenfield, Saykha; one is our existing Dyestuff business; and third will be Punjab.
Operator
operatorThe next question is from the line of [ Chinten Shah ], an individual investor. We see no response, so we'll move to the next question, which is from the line of Aditya Khetan from Stewart & Mackertich.
Aditya Khetan
analystSir, you had said to an earlier participant regarding the stable bleaching powder capacity augmentation by 60%, 70%. So is that plan included in the current presentation, what we have shared, of 270 crore caustic soda? So is that plan in there on -- in the presentation of augmentation of this -- of stable bleaching powder?
Ankit Patel
executiveYes. Yes, it is definitely included. It is not a large investment because all the infrastructure is available there. We don't have to construct anything new. We just have to order some of the machineries. And it is a batch-type process. So we have already placed orders. And since it is a brownfield, not a big investment. So we should be able to do it in 6 months' time. The current capacity is around 80 tonnes per day, where we are operating at around 75%. We are trying to take the capacity up to 120 tonnes per day. And because it is a batch type, the 80% utilization is a good number.
Aditya Khetan
analystGot it. Got it. And sir, just 1 more question on this 2 expansion of benzene derivatives and this chlor alkali. Sir, when we look at the ROCE calculations for both these projects, like I have done my own calculations, I found that the return on capital employed on both the projects, so post-tax ROCEs, are not more than 12% in each of the projects. Is this calculation correct? And secondly -- and what is the management assumptions here? And where we can think -- like if these projects are not adding value to the capital, what is the use? And just if you can shed some light on this.
Ankit Patel
executiveSo we are definitely targeting better ROCEs than that. But just as a future possibilities, we are just trying to be conservative. That's the only approach that we are going ahead with right now because there are a lot of volatilities in the market. There's still a lot of time to go. So basically, we are just being a little conservative. But overall, we feel that sulfuric acid and derivatives, with all this growth coming in from agrochemicals, pharmaceutical and mainly chemicals in the PCPIR, where we are setting up the plant, so I definitely see a very solid growth, very solid demand for all those derivatives and sulfuric acid. So that's one. And in benzene space, we are definitely replacing -- half of our products are definitely imported in big, big volumes. So we are planning to replace this indigenous production with exports. And also, all the benzene products are linked with our Dye Intermediates business, which will definitely add some more margins for us. So not to include it all, since we are doing a lot of things at the same time, right now the focus is all on the execution on time and to produce the quality product. I think marketing-wise, we have no issues at all as about 70%, 80% market, we already have -- we already are related to. So the numbers should definitely be better. It's just that we are being conservative.
Aditya Khetan
analystGot it. Got it. Sir, just one last question, one last question. Sir, in the benzene derivatives chain, majorly we are making MPDSA as a final product because others, MCB and PNCB, so they are mostly 100% captive only. So in this total capacity of 79,000 tonnes, how much would be the MPDSA finished product capacity figure? Would the -- any ballpark figure you can give, sir, for this MPDSA final product capacity?
Ankit Patel
executiveSo MPDSA is not the final product. It is the last product being produced. But -- so MCB is the only product we are going to use captively 100% in ONCB in PNCB. In ONCB, we are only using around 30% to 40% captively. So it will be sold about 60%, 70% in market. In PNCB, we are going to use about 40% -- again, 40%, 50% captively. So again, that will be sold in the market 50% to 60%. Same thing with PNA. We are going to use only about 20%. So about 80% will be sold in the market. And again, PNCB, we are going to make 2,4-DNCB. And 2,4-DNCB, again, we are only going to use about 20%. So the remaining will be -- 80% will be sold in the market. So there are all -- except for MCB, there is revenue coming from all the products. For the DNCB, it will be, again, MPDSA will be used for our Dye Intermediates business. And there again, we are only going to use about 20% -- 22% to 30%. So our MPDSA is also, again, clearly selling in the market.
Aditya Khetan
analyst[indiscernible] in the presentation is 90% captive consumption. So only 10% we are selling, right, for 2,4-DNCB?
Ankit Patel
executiveNo, I think -- I don't know which number you have seen. I'll have to check again, but I -- there is no 90% captive consumption. Only -- MCB is the only product where we are going to consume all of it. Everywhere else in any of the products, I don't have more than 40%, 50% utilization anywhere.
Operator
operatorLadies and gentlemen, due to time constraints, that was the last question for today. I now hand the conference over to Ms. Ankit Patel for closing comments.
Ankit Patel
executiveSo thank you very much, Mr. Mayur Padhya, and our advisers. And if you have any other questions which have remained unanswered, you can contact us directly, to Mayur Padhya or myself, Ankit Patel. Thank you very much. Have a good evening.
Operator
operatorThank you. On behalf of Bodal Chemicals Limited, that concludes this conference. Thank you for joining us, and you may now disconnect your lines.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete Bodal Chemicals Limited transcript — plus 255,000+ transcripts from 12,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.
Get the API View API docs →This call discussed
For developers and AI pipelines
Programmatic access to Bodal Chemicals Limited earnings transcripts and 255,000+ others is available through the
EarningsCalls.dev REST API. Plans from $24.99/month — full transcripts, speaker segments,
full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.